Inventor
MACEDONIO J. MEJIA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
H05KPrinted circuits5%
PatentTitleYear
12,351,581Compounds for FGFR inhibition202512,187,721Protein tyrosine phosphatase inhibitors202511,964,989KRas G12D inhibitors202411,884,664Protein tyrosine phosphatase inhibitors202411,634,417Protein tyrosine phosphatase inhibitors202311,453,683KRas G12D inhibitors202211,267,812KRAS G12C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARRAY BIOPHARMA INC (6)· patent assignee history
2022–2024Patents assigned to MIRATI THERAPEUTICS INC (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to COGENT BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 6 | 2022–2025 |
| MIRATI THERAPEUTICS INC | 3 | 2022–2024 |
| COGENT BIOSCIENCES INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |